59 related articles for article (PubMed ID: 12091245)
1. Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor.
Bihl MP; Heinimann K; Rüdiger JJ; Eickelberg O; Perruchoud AP; Tamm M; Roth M
Am J Respir Cell Mol Biol; 2002 Jul; 27(1):48-56. PubMed ID: 12091245
[TBL] [Abstract][Full Text] [Related]
2. Negative modulation of signal transduction via interleukin splice variation.
Denessiouk KA; Denesyuk AI; Johnson MS
Proteins; 2008 May; 71(2):751-70. PubMed ID: 17979192
[TBL] [Abstract][Full Text] [Related]
3. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
4. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
Boulanger MJ; Chow DC; Brevnova EE; Garcia KC
Science; 2003 Jun; 300(5628):2101-4. PubMed ID: 12829785
[TBL] [Abstract][Full Text] [Related]
5. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of mRNA of mouse interleukin-4 and interleukin-6.
Yatsenko OP; Filipenko ML; Khrapov EA; Voronina EN; Kozlov VA; Sennikov SV
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):190-6. PubMed ID: 15588696
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation and expression of interleukin-6 and interleukin-6Δ2 in the Tammar wallaby (Macropus eugenii).
Alsemgeest J; Old JM; Young LJ
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):139-45. PubMed ID: 23830893
[TBL] [Abstract][Full Text] [Related]
8. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
9. Novel IL-15 isoforms generated by alternative splicing are expressed in the intestinal epithelium.
Tan X; Lefrançois L
Genes Immun; 2006 Jul; 7(5):407-16. PubMed ID: 16791279
[TBL] [Abstract][Full Text] [Related]
10. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
11. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.
Turner JD; Schote AB; Keipes M; Muller CP
Ann N Y Acad Sci; 2007 Jan; 1095():334-41. PubMed ID: 17404046
[TBL] [Abstract][Full Text] [Related]
12. Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage.
Thabard W; Barillé S; Collette M; Harousseau JL; Rapp MJ; Bataille R; Amiot M
Clin Cancer Res; 1999 Oct; 5(10):2693-7. PubMed ID: 10537331
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
Cytokine; 2000 Nov; 12(11):1597-608. PubMed ID: 11052810
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics analysis of the binding of human interleukin-6 with interleukin-6 α-receptor.
Gupta M; Ha K; Agarwal R; Quarles LD; Smith JC
Proteins; 2021 Feb; 89(2):163-173. PubMed ID: 32881084
[TBL] [Abstract][Full Text] [Related]
15. Structure of the glucocorticoid receptor (NR3C1) gene 5' untranslated region: identification, and tissue distribution of multiple new human exon 1.
Turner JD; Muller CP
J Mol Endocrinol; 2005 Oct; 35(2):283-92. PubMed ID: 16216909
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes.
Kan SH; Mancini G; Gallagher G
Genes Immun; 2008 Oct; 9(7):631-9. PubMed ID: 18754016
[TBL] [Abstract][Full Text] [Related]
17. Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity.
Lissilaa R; Buatois V; Magistrelli G; Williams AS; Jones GW; Herren S; Shang L; Malinge P; Guilhot F; Chatel L; Hatterer E; Jones SA; Kosco-Vilbois MH; Ferlin WG
J Immunol; 2010 Nov; 185(9):5512-21. PubMed ID: 20870936
[TBL] [Abstract][Full Text] [Related]
18. A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor.
Alberti L; Bachelot T; Duc A; Biota C; Blay JY
Cancer Res; 2005 Jan; 65(1):2-5. PubMed ID: 15665272
[TBL] [Abstract][Full Text] [Related]
19. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
20. Expression of TGF-beta isoforms by Thy-1+ and Thy-1- pulmonary fibroblast subsets: evidence for TGF-beta as a regulator of IL-1-dependent stimulation of IL-6.
Silvera MR; Sempowski GD; Phipps RP
Lymphokine Cytokine Res; 1994 Oct; 13(5):277-85. PubMed ID: 7858060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
